Objective: To investigate in¯uences of physical mobility and season on 25-hydroxyvitamin D±intact parathyroid hormone (iPTH) interaction in the elderly. Design: We examined 188 frail institutionalized elderly at the expected nadir of their serum vitamin D concentrations (winter). This group was compared with 309 healthy ambulatory elderly at the expected time of maximum vitamin D repletion (summer), to accentuate the in¯uences of season and physical activity. Methods: Serum concentrations of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, iPTH and urinary deoxypyridinoline (DPD) were measured. Results: Vitamin D metabolites were signi®cantly lower in the institutionalized elderly (P<0.0001), with an 82.5% prevalence of vitamin D de®ciency (25-hydroxyvitamin D <12 ng/ml) in institutionalized elderly in wintertime and 15.5% in ambulatory elderly in summertime. Overall, median iPTH did not differ between groups. However, median iPTH secretion in the presence of low vitamin D serum concentrations (5±30 ng/ml) was greater in ambulatory elderly. This could be explained by lower mobility status being correlated with greater serum calcium concentrations (r=0.24, P=0.02 in women; r=0.35, P=0.001 in men) and greater urinary excretion of DPD (r=0.41, P=0.0001 in women; r=0.42, P=0.0002 in men), independent of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and iPTH. Conclusions: These data support the hypothesis that immobility, even in the presence of vitamin D de®ciency, acts as an overriding in¯uence on bone metabolism by promoting bone resorption (measured as urinary DPD) and increasing serum calcium independent of iPTH. Therefore mobility status may substantially affect 25-hydroxyvitamin D threshold values and the degree to which patients bene®t from vitamin supplementation.
Introduction
Vitamin D is needed to maintain calcium absorption and skeletal integrity (1±4). It has been suggested that the evolution of osteoporosis in the elderly is promoted by hypovitaminosis D and secondary hyperparathyroidism (28 HPT). The consequence of an increase in parathyroid hormone (PTH) would be an increase in bone remodeling activity, which is re¯ected in documented abnormalities of bone biomarkers and fragility fractures (5) . The threshold concentrations of 25-hydroxyvitamin D below which these abnormalities occur are being de®ned by current research (6, 7) . Even small increases in PTH concentrations may have potentially harmful bone effects. Recent studies have shown that threshold levels of 25-hydroxyvitamin D needed by elderly patients to restore PTH concentrations to the low values seen in young adults might be greater than the lower physiological threshold proposed by Lips (12 ng/ml, 30 nmol/l) (7) .
In a recent publication McKenna & Freaney (6) de®ned vitamin D thresholds below which occurrence of 28 HPT and abnormalities in bone metabolism are expected. They de®ned four levels of 25-hydroxyvitamin D including desirable 25-hydroxyvitamin D status (>100 nmol/l, >40 ng/ml), hypovitaminosis D (<100 nmol/l, <40 ng/ml), vitamin D insuf®ciency (<50 nmol/ l, <20 ng/ml) and vitamin D de®ciency (<25 mmol/l, <10 ng/ml). Thresholds differ between studies, which might be in¯uenced by age and by life-style factors such as sedentary status and physical mobility. For example, irrespective of the country of residence, communitydwelling elderly have greater 25-hydroxyvitamin D and lower PTH serum concentrations than housebound or institutionalized elderly. European studies tend to document lower 25-hydroxyvitamin D concentrations and greater PTH than their counterparts in the USA, Australia or Japan (3, 4) , which is probably due to a lack of vitamin-D-forti®ed food in Europe. Moreover, young people seem to have a different threshold for increased PTH than do elderly people (8) . Impaired function of 1a-hydroxylase in the ageing kidney has been proposed as a possible mechanism (8) .
The aim of the present study was to investigate a particular lifestyle factor, physical mobility, that might in¯uence the threshold relationship between 25-hydroxyvitamin D and intact (iPTH) in the elderly. Therefore two groups of elderly individuals, selected to differ markedly in their levels of weight-bearing activity and risk factors for vitamin D de®ciency, such as season and sedentary status, were compared for their serum vitamin D concentrations, their corresponding iPTH serum concentrations, and biochemical markers of bone remodelling.
Methods

Participants
A total of 495 elderly people were enrolled in a crosssectional study between January 1995 and August 1995. They were categorized according to sex and living situation: 309 ambulatory elderly people (107 women: mean age 74 years, range: 62±86 years; 202 men: mean age 76 years, range: 66±95 years) and 188 institutionalized geriatric residents (103 women: mean age 83 years, range: 59±99 years; 85 men: mean age 78 years, range: 56±94 years). The demographic characteristics of the participants are shown in Table 1 .
All institutionalized elderly people were recruited from the long-stay geriatric unit of the University Hospital, Basel. Mean duration of stay was 32 weeks (women 26 weeks; men 39 weeks). Measurements took place between January and March (wintertime) in the institutionalized group, and between April and August (summertime) in the ambulatory group, in an attempt to accentuate as much as possible the differences in serum vitamin D hormone concentrations (25-hydroxyvitamin D, 1,25-dihydroxyvitamin D) in the elderly population.
All ambulatory elderly people lived independently and were able to walk alone, a minority using a walking stick for ambulation.
The ambulatory group were part of the Basel longitudinal Inter-Disciplinary Study on Ageing (IDA) project, which has been in progress since 1993 (9) . The project is a follow-up to a medical longitudinal study, the Basle Prospective Study, that collected biomedical data from a large sample of 6400 healthy people in 1960, 1965 and 1971 (10) . For the continuing IDA study, the participants were required to be 65 years or older. The ambulatory group was selected by random sampling from the large sample that comprised 2959 men and 809 women in 1993.
Each participant was assigned to one of ®ve physical activity groups based on three sources of information: the participant's own assessments of their physical activity were elicited, together with the observations of nursing staff in the institutionalized group and one physician investigator. If the participant was unable to provide a reliable assessment, the family was consulted. The observations rarely disagreed. Physical activity group 0 comprised those who walked outside more than twice a week. All ambulatory elderly were in this group, but no institutionalized elderly person was. Physical activity groups 1±4 included only the institutionalized elderly. Those assigned to activity group 1 were able to walk independently, a minority using a walking stick for ambulation; they were able to walk outside once or twice a week. Participants assigned to activity group 2 were less physically active, the majority using a walking stick or a walking frame; they left the facility less than once weekly, but required no wheelchair. Activity group 3 included persons most of whom required wheelchairs, but who spent more than 50% of their day sitting, rather than lying in bed. Group 4 comprised bedridden elderly, who spent more than half of each day in bed.
The study procedure was approved by the hospital ethics commitee. Oral informed consent was obtained from all participants or from their legal guardians. Participants had not received any treatment for a bone disorder with calcium, vitamin D, hormone replacement therapy, calcitonin,¯uoride, or bisphosphonates during the previous 6 months. Exclusion criteria were a history of recent hip fracture (within 3 years), history of hypercalcemia, urolithiasis, sarcoidosis and primary HPT. Individuals with creatinine values greater than the normal range (<120 mmol/l) were excluded. Current calcium intake was measured in the ambulatory individuals by means of a frequency and amount questionnaire, which contained information about the consumption of 15 food items: milk, yoghurt, hard cheese, soft cheese, chocolate, meat or ®sh, eggs, potatoes, pasta, vegetables, bread, fruits, water or mineral water, alcoholic beverages, or fruit juice. For the institutionalized elderly, a dietitian evaluated the mean calcium content of food consumed from each meal and drink during the week of baseline measurements.
All measurements were performed locally at the Geriatric University Hospital of Basel (latitude 47,338 North; longitude 7,358 East).
Samples and assays
Fasting early morning venous blood was collected from resting individuals for measurement of serum concentrations of calcium, phosphate, albumin and total alkaline phosphatase. These substances were measured using automated serum chemical analysis. Blood calcium concentration was corrected for albumin with the following formula: corrected calcium measured calcium (mmol/l) À 0.012´(albumin(g/l) À 39.5) (11) .
iPTH serum concentration was measured by an immunoradiometric assay (Intact PTH; Nichols) in EDTA plasma. The upper normal limit, indicating 28 HPT, was set at >54 pg/ml (7). On two separate determinations, intra-assay variation was 1.8 and 3.4% and interassay variation 5.6 and 6.1%.
For 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D serum concentration measurements, radioimmunoassays (Nichols, San Juan Capistrano, CA, USA) were used (vitamin D de®ciency was de®ned as 25-hydroxyvitamin D serum concentrations less than 12 ng/ml or 30 nmol/l (12)). Intra-assay variation was 5.1 and 9.2% and interassay variation 7.9 and12.6% for the 25-hydroxyvitamin D assay; respective variations were 4.8 and 10.6%, and 10.8 and 16.8%, for the 1,25-dihadroxyvitamin D assay.
Urinary deoxypyridinoline (DPD) was measured by reverse-phase ion-paired HPLC after complete acid hydrolysis of the urine and prefractionation of the hydrolysate on a CF-1 cellulose column (NTx, Osteomark, Seattle, WA, USA). The intra-and interassay variations were 4.6% and 10.2%. DPD determinations 
Results
A total of 495 participants were enrolled in the study. Their characteristics are shown in Table 1 . Median values obtained for measured parameters in women and men of both categories are summarized in Table 2 . Signi®cant differences were found in concentrations of serum vitamin D metabolites (calcidiol, calcitriol), albumin and urinary DPD excretion. Calcium intake was low in both groups (institutionalized: 600±700 mg/day; ambulatory: 500±700 mg/day). Vitamin D status in institutionalized elderly at the expected nadir (wintertime) compared with ambulatory elderly at the expected maximum (summertime) are depicted in Fig. 1 (6) . Severe vitamin D de®ciency (25-hydroxyvitamin D <5 ng/ml; <15 nmol/l) was found in 107 institutionalized elderly (56.9%) in wintertime and 13 ambulatory elderly (4.2%) in summertime. The prevalence of vitamin D de®ciency (25-hydroxyvitamin D <12 ng/ml; <30 nmol/l) was 82.5% (155 individuals) in institutionalized elderly, compared with 15.5% (48 individuals) in ambulatory elderly. Vitamin D insuf®ciency (25-hydroxyvitamin D 12±19 ng/ml; 30±49 nmol/l) was present in 10.1% (19 individuals) of institutionalized and 19.7% (61 individuals) of ambulatory elderly. Twelve institutionalized elderly (6.4%) and 95 ambulatory elderly (30.7%) had hypovitaminosis D (25-hydroxyvitamin D 20±40 ng/ml; 50±100 nmol/l). Desirable vitamin D status (>40 ng/ml; >100 nmol/l) was attained in two institutionalized elderly (1.1%) and 105 ambulatory elderly (34.1%).
In an ANCOVA, including all participants, life-style plus season, iPTH and age explained 55% (r 2 0:55) of total variation of ln(25-hydroxyvitamin D).
Vitamin D metabolites and prevalence of 28 HPT
Median 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D serum concentrations of institutionalized elderly measured during January to March differed signi®-cantly from the mean summer values in ambulatory elderly (Table 2) .
Median serum iPTH concentrations were slightly greater in women than in men in both groups (institutionalized: 40.5 pg/ml in women and 34.0 pg/ml in men, compared with ambulatory: 42.0 pg/ml in women and 37.5 pg/ml in men), but did not differ signi®cantly between institutionalized and ambulatory elderly. Using an upper normal limit for iPTH of 54 pg/ml, 28 HPT occurred in 22% of female and 15% of male participants in the ambulatory group, and in 25% of female and 21% of male participants in the institutionalized group.
In both groups, 25-hydroxyvitamin D and iPTH serum concentrations were negatively correlated (institutionalized: r À0:29, P 0:003 in women and r À0:33, P 0:003 in men; ambulatory: r À0:24, P 0:01 in women and r À0:26, P 0:0002 in men). Intact PTH serum concentrations increased with age in the institutionalized elderly 
Relationship between 25-hydroxyvitamin D and iPTH serum concentrations
Median iPTH serum concentrations for 5 ng/ml increments of 25-hydroxyvitamin D serum concentrations for institutionalized and ambulatory elderly are shown in Fig. 2 . In institutionalized elderly, median serum iPTH concentrations were about 30 pg/ml for 25-hydroxyvitamin D concentrations ranging from 6 to 30 ng/ml. In the ambulatory group, median iPTH serum concentrations were between 40 and 50 pg/ml iPTH at serum concentrations of 25-hydroxyvitamin D ranging from 1 to 30 ng/ml. Institutionalized elderly attained iPTH serum concentrations greater than 40 pg/ml only as serum concentrations of 25-hydroxyvitamin D decreased to less than 6 ng/ml. In both groups, lowest iPTH serum concentrations were found in 25-hydroxyvitamin D concentrations >30 ng/ml; however, there was a greater median iPTH serum concentration in the ambulatory group.
Vitamin D, iPTH and bone resorption
Urinary DPD excretion was measured as a marker for bone resorption. Both sexes showed greater values for urinary DPD excretion rate in the institutionalized group (P 0:0001). In the institutionalized elderly, no correlation was found between serum iPTH or 25-hydroxyvitamin D and urinary DPD or mobility score. Box plot for urinary DPD concentrations in ®ve mobility groups: ambulatory elderly (fully mobile, n 303) and institutionalized elderly (mobile, n 55; walking aid, n 41; wheelchair, n 42; bedridden, n 29). There was an increased excretion of DPD in more immobile groups.
However, a positive correlation was documented between mobility score and both serum calcium (women: r 0:24, P 0:02; men: r 0:35, P 0:001) and urinary DPD (women: r 0:41, P 0:0001; men: r 0:42, P 0:0002). Urinary calcium/creatinine ratio was greater in institutionalized elderly (women: P 0:0001, men: P 0:0001). Box plots for urinary DPD were compared for ®ve mobility groups and are shown in Fig. 3 . In an ANCOVA, including institutionalized and ambulatory elderly, only the level of physical mobility reached signi®cance and explained 20.3% of total variation of DPD excretion. Other factors tested in this model were vitamin D metabolites, iPTH, albumin, serum calcium, alkaline phosphatase, sex, body mass index, age and sedentary status. If ambulatory elderly were analysed separately, none of these factors reached signi®cance, and a combination of all factors explained 16.7% of total variation of DPD excretion.
Discussion
These results indicate that, in Switzerland, vitamin D de®ciency is common in institutionalized elderly during wintertime (83%), but much less common in ambulatory elderly during summertime (16%). However, only 34% of ambulatory elderly in summertime showed desirable 25-hydroxyvitamin D serum concentrations (>40 ng/ml; >100 nmol/l) as proposed by McKenna & Freaney (6) . Low 25-hydroxyvitamin D serum concentrations in the institutionalized population and high 25-hydroxyvitamin D serum concentrations in ambulatory elderly were, as expected, predicted by seasonality and residential status (4, 13). As only 34% of ambulatory elderly in summertime had desirable 25-hydroxyvitamin D serum concentrations (>40 ng/ml), and 16% were vitamin-Dde®cient (<12 ng/ml), our results indicate that, even for our lower-risk group of independently living elderly, vitamin D supplementation should be recommended in order to restore iPTH concentrations in the elderly to those found in young adults (14) .
Contrary to expectations and despite major differences in vitamin D status and age, equal median serum concentrations of iPTH were seen in ambulatory elderly in summertime and institutionalized elderly in wintertime. In fact, we would have expected increased median iPTH in institutionalized elderly, because of both lower 25-hydroxyvitamin D concentrations and greater age (1, 2, 6) . Another unexpected ®nding was that neither 25-hydroxyvitamin D nor iPTH serum concentrations correlated with bone resorption as measured by urinary excretion of DPD. However, more immobile individuals had greater serum calcium concentrations and greater excretion rates for urinary DPD. Therefore the increase in bone resorption in the group of institutionalized elderly could be related to immobility, rather than to 28 HPT. This might be explained by an immobilityinduced increase in serum calcium as a result of bone resorption and resulting suppression of serum iPTH concentrations. The uncoupling of the 25(OH)D±PTH axis is re¯ected in a rather low incidence (25% of female and 21% of male institutionalized elderly) of 28 HPT (iPTH >55 pg/ml) in a population with a high incidence of vitamin D de®ciency (83%). We conclude that, in institutionalized elderly, immobility has a strong impact on bone metabolism. This might counteract the development of 28 HPT through increased serum calcium (15) , which is consistent with our ®nding of a positive correlation between mobility score and both serum calcium and urinary DPD. These results are similar to those seen in younger persons during shortterm bed rest (16) and in astronauts during space¯ight (17) , with primary bone loss as a result of immobility or weightlessness-induced negative calcium balance. In addition Sorva and colleagues (18) reported that bedridden elderly patients do not bene®t from vitamin D supplementation with increased bone resorption, which is in contrast to the ®ndings of studies performed in more mobile elderly populations (5).
However, despite this strong in¯uence of immobility on 25-hydroxyvitamin D and iPTH interaction, correlation studies between 25-hydroxyvitamin D and iPTH remained signi®cant and were more pronounced in institutionalized elderly than in ambulatory elderly. Therefore both vitamin D de®ciency, as suggested by Chapuy and colleagues (14) , and immobility, as suggested by the present data, in¯uence serum PTH concentrations. Nevertheless bone resorption seems to be driven by immobility, and if present, even in vitamin-D-de®cient elderly.
The suggested impact of mobility status on serum iPTH concentrations might in¯uence threshold values of 25-hydroxyvitamin D, which have been found to vary (6) . On the basis of a comparison of reports in the elderly of baseline vitamin D and PTH status and the response to vitamin D therapy, McKenna & Freaney (6) proposed a threshold concentration greater than 40 ng/ml (>100 nmol/l), whereas Lips and colleagues (12) proposed the much lower value of 30 nmol/l (12 ng/ml). Chapuy and colleagues (7) demonstrated, in the Decalyos study, a threshold concentration of 105 nmol/l at which prevention of hip fracture by supplementation of vitamin D and calcium occurred. In another study by DawsonHughes and colleagues (19) , a threshold concentration of 44 ng/ml (110 nmol/l) could be de®ned on the basis of PTH status in North American elderly. Findings of the SUVIMAX study of middle-aged adults in France suggested a threshold of 31 ng/ml (78 nmol/l), on the basis of the relationship between 25-hydroxyvitamin D and PTH serum concentrations (7) . In a collaborative study on vitamin D status, Lips and colleagues (20) suggested that serum 25-hydroxyvitamin D values cannot be assumed to be comparable, without a careful cross-calibration between different laboratories for 25-hydroxyvitamin D assays. This might explain a signi®cant part of the variation between the 25-hydroxyvitamin D threshold studies stated above, suggesting that understanding of desirable vitamin D concentrations in the elderly may need to take between-assay variations into consideration.
In this study, we investigated differences in 25-hydroxyvitamin D±iPTH interaction between ambulatory elderly in summertime (expected maximum vitamin D repletion) and institutionalized elderly in wintertime (expected nadir in vitamin D status). The relationship between 25-hydroxyvitamin D (5 ng/ml increments) and iPTH serum concentrations differed markedly between ambulatory elderly in summertime and institutionalized elderly in wintertime, although their overall median iPTH serum concentrations were similar. In institutionalized elderly, median serum iPTH concentrations were about 30 pg/ml for 25-hydroxyvitamin D concentrations between 6 and 30 ng/ml, whereas in ambulatory elderly the median iPTH serum concentrations were greater, between 40 and 50 pg/ml at low vitamin D concentrations. Institutionalized elderly attained median iPTH serum concentrations greater than 40 pg/ml only as serum concentrations of 25-hydroxyvitamin D decreased to less than 6 ng/ml. These ®ndings could be explained by the immobility-induced bone loss in the institutionalized elderly, proposed above, which might pre-empt the development of 28 HPT by increasing bone resorption and serum calcium. Assay variation could not be an explanation for differences between ambulatory and institutionalized elderly within this study, as the same assay was used by one laboratory for all participants.
Our results show that, although the incidence of vitamin D de®ciency was about six times greater in institutionalized elderly in wintertime, mean iPTH serum concentrations were similar to those of ambulatory elderly in summertime. Bone turnover was associated with low physical mobility, but not with vitamin D de®ciency or iPTH concentrations.
The clinical implications of these ®ndings would suggest that interventions aimed at increasing physical mobility may prove useful in augmenting the effect of vitamin D supplementation in frail elderly. In addition, our results suggest that a further re®nement of the understanding of desirable vitamin D concentrations in the elderly may need to take levels of activity into consideration.
